Longitudinal molecular trajectories of diffuse glioma in adults
2019 · Nature · 563 citations
https://doi.org/10.1038/s41586-019-1775-1
J
Jelle Wesseling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
647
Papers
22.2K
Citations
73
h-index
251
i10-index
Jelle Wesseling is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & Breast Lesions and Carcinomas. The author has an h-index of 73, co-authored 550 publications.
ORCID: 0000-0002-8940-2676Papers by this author
worksIdentification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017 · Nature Genetics · 464 citations
https://doi.org/10.1038/ng.3785
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
2018 · The Lancet Oncology · 421 citations
https://doi.org/10.1016/s1470-2045(18)30570-9
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
2020 · Nature Reviews Clinical Oncology · 416 citations
https://doi.org/10.1038/s41571-020-0388-9
Ductal carcinoma in situ: to treat or not to treat, that is the question
2019 · British Journal of Cancer · 329 citations
https://doi.org/10.1038/s41416-019-0478-6
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat